Diagenic, Opaldia unite for UK blood test deal
This article was originally published in Clinica
Executive Summary
Norwegian lifesciences specialist DiaGenic has teamed up with healthcare provider Opaldia to make its gene expression tests available in the UK. The two companies will make the technology, which consists of tests for Alzheimer's disease and breast cancer, available to private patients in the UK.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.